Recombinant Ferritin antibody (full length, Light Chain)
Quick Overview for Recombinant Ferritin antibody (full length, Light Chain) (ABIN7879492)
Target
See all Ferritin (FE) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- full length, Light Chain
-
Purpose
- Recombinant Ferritin Light Chain Antibody / FTL
-
Purification
- Protein A affinity chromatography
-
Immunogen
- Recombinant full-length human FTL protein was used as the immunogen for the recombinant Ferritin Light Chain antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal dilution of the recombinant Ferritin Light Chain antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the recombinant Ferritin Light Chain antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Ferritin (FE)
-
Alternative Name
- Ferritin
-
Background
- Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
-
UniProt
- P02792
-
Pathways
- Transition Metal Ion Homeostasis
Target
-